Prof. Seiichi Taguchi
Institute of Science Tokyo
"Large-scale bioproduction of a target molecule remains a major challenge for academic institutions. Thanks to BioPhenolics’ comprehensive support and close collaboration throughout the technology transfer process—from initial process design to final reporting—we were able to demonstrate excellent reproducibility and successfully replicate the production process.
This outcome has established a strong and reliable foundation for future scale-up activities, making BioPhenolics a trusted partner for translating research into scalable manufacturing".
Contract Biomanufacturing for the Next Generation of Sustainable Chemistry
BioCDMO is BioPhenolics’ contract development and manufacturing service for startups and chemical companies seeking to scale bio-based products from the lab to commercial production.
From culture optimization, process development to pilot-scale validation, we work alongside your team to de-risk scale-up and accelerate commercialization of proteins, specialty chemicals, and other biologically produced compounds.
Our approach is practical, performance‑driven, and industry‑aligned—ideal for partners who value real‑world execution over theoretical concepts.
BioPhenolics Business Model - BIO CDMO
Our Business Model
Your Cells
1. Cultivation process development
2. Downstream process development
3. Scale Up
What We Offer
End-to-End Bioproduction Services
1. Custom Bioproduct Development
We develop microbial production processes for a wide range of products, including specialty chemicals, amino acids, peptides, recombinant proteins, antibodies, and other biologically derived compounds.
2. Precision Fermentation & Scale‑Up
From bench‑scale to pilot‑scale (10,000 L), we optimize fermentation conditions for yield, purity, and industrial compatibility.
3. Bioprocess R&D
Our expert team bridges the gap between biological innovation and industrial manufacturing through practical, application-driven process development.
4. Technology Transfer & Licensing
Partners can access and license our proprietary strain engineering and bioprocess development technologies to accelerate internal production programs.
5. Joint Development Partnership
We work closely with clients to co-develop, validate, and commercialize scalable biomanufacturing processes tailored to their product and market needs.
Why Companies Choose BioCDMO
A Practical, Industry‑Ready Approach to Biomanufacturing
Advanced Process Engineering
We combine microbial engineering, fermentation optimization, and process development to maximize productivity, robustness, and scalability.
Scalable Manufacturing Pathways
Our development approach is designed to facilitate smooth transition from laboratory research to pilot and commercial-scale production.
Accelerated Development
By integrating strain development, process optimization, and scale-up expertise, we help reduce technical risk and shorten time-to-market.
Tailored to Your Product
Every program is customized to your target molecule, production requirements, quality specifications, and commercial objectives.
Industries We Serve
Cross‑Industry Applications
Cosmetics
Antioxidants, preservatives, active ingredients
Electronics
High‑purity compounds for coatings and components
Food & Flavor
Natural aromatic compounds
Plastics
Bio‑based monomers and polymer precursors
Adhesives
Sustainable alternatives to petrochemical compounds
Material Science
High‑performance bio‑derived materials
Our Process
From Concept to Commercialization
Step‑by‑Step Layout:
-
Discovery & Compound Selection
-
Identify the phenolic or aromatic compound required for your application.
-
-
Microbial Pathway Engineering
-
We design and optimize metabolic pathways for high‑efficiency production.
-
-
Fermentation Optimization
-
Bench‑scale testing to refine yield, purity, and process stability.
-
-
Pilot‑Scale Production
-
Scale up to 10,000 L fermentation for validation and sampling.
-
-
Commercialization Support
-
Joint development, licensing, and technology transfer options available.
-
A Scalable Platform Positioned for Global Demand
BioCDMO is not just a service—it is a commercialization engine for sustainable chemistry.
Investors gain exposure to:
A $15B+ global phenolics market
Rapidly growing demand for bio‑based raw materials
A defensible technology platform built on decades of research
Multi‑industry applicability and diversified revenue streams
A clear roadmap toward commercial biofactories in Southeast Asia